{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:30:46Z","timestamp":1786667446867,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13786-6","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T04:54:59Z","timestamp":1780894499000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of prior TB preventive therapy on all-cause mortality during TB treatment among people with HIV\/TB in rural eastern Uganda: an observational causal analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Jonathan","family":"Izudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Bajunirwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saadick Mugerwa","family":"Ssentongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidi","family":"Appeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithya","family":"Cattamanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,8]]},"reference":[{"issue":"2","key":"13786_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40265-024-02131-3","volume":"85","author":"V Chihota","year":"2025","unstructured":"Chihota V, Gombe M, Gupta A, Salazar-Austin N, Ryckman T, Hoffmann CJ, et al. Tuberculosis Preventive Treatment in High TB-Burden Settings: A State-of-the-Art Review. Drugs. 2025;85(2):127\u201347.","journal-title":"Drugs"},{"key":"13786_CR2","doi-asserted-by":"publisher","first-page":"513967","DOI":"10.1155\/2011\/513967","volume":"2011","author":"KA Wilkinson","year":"2011","unstructured":"Wilkinson KA, Schwander S, Torok ME, Meintjes G. Human immunodeficiency virus-associated tuberculosis. Clin Dev Immunol. 2011;2011:513967.","journal-title":"Clin Dev Immunol"},{"key":"13786_CR3","doi-asserted-by":"publisher","first-page":"107876","DOI":"10.1016\/j.ijid.2025.107876","volume":"155","author":"B Sossen","year":"2025","unstructured":"Sossen B, Kubjane M, Meintjes G. Tuberculosis and HIV coinfection: Progress and challenges towards reducing incidence and mortality. Int J Infect Dis. 2025;155:107876.","journal-title":"Int J Infect Dis"},{"issue":"4","key":"13786_CR4","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s15010-024-02215-y","volume":"52","author":"I Su\u00e1rez","year":"2024","unstructured":"Su\u00e1rez I, Rauschning D, Sch\u00fcller C, Hagemeier A, Stecher M, Lehmann C, et al. Incidence and risk factors for HIV-tuberculosis coinfection in the Cologne-Bonn region: a retrospective cohort study. Infection. 2024;52(4):1439\u201348.","journal-title":"Infection"},{"key":"13786_CR5","doi-asserted-by":"crossref","unstructured":"Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, et al. The growing importance of tuberculosis preventive therapy and how research and innovation can enhance its implementation on the ground. Trop Med Infect Dis. 2020;5(2).","DOI":"10.3390\/tropicalmed5020061"},{"issue":"sup1","key":"13786_CR6","first-page":"77","volume":"6","author":"GG Alvarez","year":"2022","unstructured":"Alvarez GG, Pease C, Menzies D. Chapter 6: Tuberculosis preventive treatment in adults. Can J Respiratory Crit Care Sleep Med. 2022;6(sup1):77\u201386.","journal-title":"Can J Respiratory Crit Care Sleep Med"},{"key":"13786_CR7","volume-title":"Global Tuberculosis Report 2024","author":"World Health Organization (WHO)","year":"2024","unstructured":"World Health Organization (WHO). Global Tuberculosis Report 2024. Switzerland: Geneva; 2024."},{"issue":"10","key":"13786_CR8","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/S1473-3099(13)70187-7","volume":"13","author":"B Durovni","year":"2013","unstructured":"Durovni B, Saraceni V, Moulton LH, Pacheco AG, Cavalcante SC, King BS, et al. Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013;13(10):852\u20138.","journal-title":"Lancet Infect Dis"},{"key":"13786_CR9","first-page":"9741157","volume":"2024","author":"K Nigussie","year":"2024","unstructured":"Nigussie K, Gebeye E, Kifle ZD, Tadesse TY, Birarra MK. Impact of Isoniazid Preventive Therapy on Tuberculosis Incidence and Predictors of Tuberculosis Among People Living With HIV\/AIDS at Debre Tabor General Hospital, Northwest Ethiopia. Tuberc Res Treat. 2024;2024:9741157.","journal-title":"Tuberc Res Treat"},{"key":"13786_CR10","doi-asserted-by":"crossref","unstructured":"Agarwal R, Nyendak M, Chava N, Allam RR, Moonan PK, Sriram CS, et al. Long-term protection from TB preventive treatment among people with HIV in a high-burden tuberculosis setting: an observational cohort study from India. Clin Infect Dis. 2025.","DOI":"10.1093\/cid\/ciaf322"},{"key":"13786_CR11","doi-asserted-by":"crossref","unstructured":"Gomes VF, Andersen A, Lemvik G, Wejse C, Oliveira I, Vieira FJ, et al. Impact of isoniazid preventive therapy on mortality among children less than 5 years old following exposure to tuberculosis at home in Guinea-Bissau: a prospective cohort study. BMJ Open. 2013;3(3).","DOI":"10.1136\/bmjopen-2012-001545"},{"issue":"8","key":"13786_CR12","first-page":"Cd006418","volume":"8","author":"M Zunza","year":"2017","unstructured":"Zunza M, Gray DM, Young T, Cotton M, Zar HJ. Isoniazid for preventing tuberculosis in HIV-infected children. Cochrane Database Syst Rev. 2017;8(8):Cd006418.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"13786_CR13","doi-asserted-by":"publisher","first-page":"e8","DOI":"10.1016\/S2352-3018(20)30299-X","volume":"8","author":"JM Ross","year":"2021","unstructured":"Ross JM, Badje A, Rangaka MX, Walker AS, Shapiro AE, Thomas KK, et al. Isoniazid preventive therapy plus antiretroviral therapy for the prevention of tuberculosis: a systematic review and meta-analysis of individual participant data. Lancet HIV. 2021;8(1):e8\u201315.","journal-title":"Lancet HIV"},{"key":"13786_CR14","doi-asserted-by":"publisher","first-page":"102209","DOI":"10.1016\/j.eclinm.2023.102209","volume":"64","author":"AM Liyew","year":"2023","unstructured":"Liyew AM, Gilmour B, Clements ACA, Alene KA. Comparative effectiveness of interventions for preventing tuberculosis: systematic review and network meta-analysis of interventional studies. EClinicalMedicine. 2023;64:102209.","journal-title":"EClinicalMedicine"},{"key":"13786_CR15","volume-title":"Guidelines for the prevention and treatment of HIV and AIDS in Uganda","author":"Republic of Uganda","year":"2022","unstructured":"Republic of Uganda. Guidelines for the prevention and treatment of HIV and AIDS in Uganda. Kampala, Uganda: Ministry of Health; 2022."},{"key":"13786_CR16","volume-title":"Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda","author":"Republic of Uganda","year":"2022","unstructured":"Republic of Uganda. Consolidated guidelines for the prevention and treatment of HIV and AIDS in Uganda. Kampala, Uganda: Ministry of Health; 2022."},{"issue":"1","key":"13786_CR17","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1186\/s12879-025-11618-7","volume":"25","author":"SM Ssentongo","year":"2025","unstructured":"Ssentongo SM, Kwenya K, Oryokot B, Opito R, Alwedo S, Ochieng G, et al. The treatment success rate and associated factors among pulmonary bacteriologically confirmed and pulmonary clinically diagnosed drug susceptible TB coinfected with HIV in Teso Sub-Region, North-Eastern Uganda 2020\u20132021. a retrospective study. BMC Infect Dis. 2025;25(1):1249.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"13786_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12874-025-02553-x","volume":"25","author":"J Izudi","year":"2025","unstructured":"Izudi J, Cattamanchi A, Bajunirwe F. Causal inference methodologies to assess the effect of missed clinic visits on treatment success rate among people with tuberculosis in rural Uganda. BMC Med Res Methodol. 2025;25(1):104.","journal-title":"BMC Med Res Methodol"},{"issue":"12","key":"13786_CR19","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. Int J Surg (London England). 2014;12(12):1500\u201324.","journal-title":"Int J Surg (London England)"},{"issue":"5","key":"13786_CR20","doi-asserted-by":"publisher","first-page":"e0266285","DOI":"10.1371\/journal.pone.0266285","volume":"17","author":"A Kazibwe","year":"2022","unstructured":"Kazibwe A, Oryokot B, Mugenyi L, Kagimu D, Oluka AI, Kato D, et al. Incidence of tuberculosis among PLHIV on antiretroviral therapy who initiated isoniazid preventive therapy: A multi-center retrospective cohort study. PLoS ONE. 2022;17(5):e0266285.","journal-title":"PLoS ONE"},{"issue":"1","key":"13786_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12879-016-2109-7","volume":"17","author":"M Semu","year":"2017","unstructured":"Semu M, Fenta TG, Medhin G, Assefa D. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV\/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study. BMC Infect Dis. 2017;17(1):5.","journal-title":"BMC Infect Dis"},{"issue":"0 5","key":"13786_CR22","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1097\/01.aids.0000391010.02774.6f","volume":"24","author":"S Charalambous","year":"2010","unstructured":"Charalambous S, Grant AD, Innes C, Hoffmann CJ, Dowdeswell R, Pienaar J, et al. Association of isoniazid preventive therapy with lower early mortality in individuals on antiretroviral therapy in a workplace programme. Aids. 2010;24(0 5):S5\u201313.","journal-title":"Aids"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13786-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13786-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:11:57Z","timestamp":1786666317000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13786-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13786"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13786-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-8406265\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,8]]},"assertion":[{"value":"19 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval and a waiver of informed consent were obtained from the Mbale Hospital Research and Ethics Committee (approval number: MRRH-2025-558). Confidentiality was maintained by using de-identified, encrypted, and password-protected patient-level data accessible only to the authorized study team. Administrative clearance to access and use medical records was obtained from the heads of each participating health facility. The study was conducted in accordance with the principles of the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1480"}}